RBC Capital Sticks to Their Hold Rating for Moderna (MRNA)
In a report released on January 7, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
EconoTimes1d
RBC Upgrades Utilities Sector While Downgrading Energy
RBC Capital Markets has upgraded the Utilities sector to Overweight, naming it the top defensive sector, while downgrading ...
E&E23h
Exxon drops after warning of oil, refining hit to 4Q profit
Exxon Mobil’s shares fell after the company warned its fourth-quarter earnings will take a hit from lower crude prices and narrowing refining margins during the final three months of 2024.
RBC Capital Reaffirms Their Hold Rating on RPM International (RPM)
In a report released on January 8, Arun Viswanathan from RBC Capital maintained a Hold rating on RPM International (RPM – Research Report), ...
ca.investing.com on MSN2d
Carvana stock jumps as RBC lifts rating to Buy
RBC Capital Markets on Monday upgraded Carvana (NYSE:CVNA) shares to Outperform, and lifted the target price to $280 from $270.
Top 30 global stock ideas from RBC Capital Markets analysts
The research team at RBC Capital Markets published their top 30 global stock ideas for 2025, ...
Wall Street cuts Exxon earnings views after fourth-quarter snapshot
Exxon Mobil shares fell nearly 2% in early trading on Wednesday after the top U.S. oil producer warned of a decline in ...
BMO stock gets 20% price target hike, upgrade to 'Outperform' from RBC
Mihelic hiked his price target on Toronto-listed BMO shares from $133 to $161, while upgrading his rating to “Outperform” ...
RBC quantitative analyst makes 10 changes to his top 40 Canadian stock picks
Scotiabank analyst Mario Saric thinks the worst may be over for domestic office REITs, ...
Exxon signals weaker performance across the board to hurt Q4 profits
Exxon Mobil signaled on Tuesday that sharply lower oil refining profits and weakness across all its businesses would reduce ...
RBC Capital Remains a Buy on Nasdaq (NDAQ)
RBC Capital analyst Ashish Sabadra maintained a Buy rating on Nasdaq (NDAQ – Research Report) yesterday and set a price target of $95.00. The ...